Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short-term safety of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study.
Tamura T, Ninomiya K, Kubo T, Kuyama S, Tachibana S, Inoue K, Chikamori K, Kudo K, Ochi N, Harada D, Maeda Y, Kiura K. Tamura T, et al. Among authors: harada d. Thorac Cancer. 2022 Feb;13(3):453-459. doi: 10.1111/1759-7714.14281. Epub 2021 Dec 28. Thorac Cancer. 2022. PMID: 34964270 Free PMC article.
Obstructive jaundice at the initial presentation in small-cell lung cancer.
Ochi N, Takigawa N, Yasugi M, Ishida E, Kawamoto H, Taniguchi A, Harada D, Hayashi E, Toda H, Yanai H, Tanimoto M, Kiura K. Ochi N, et al. Among authors: harada d. Int Med Case Rep J. 2010 Feb 25;3:9-12. doi: 10.2147/imcrj.s8093. Print 2010. Int Med Case Rep J. 2010. PMID: 23754881 Free PMC article.
The Role of STAT3 in Non-Small Cell Lung Cancer.
Harada D, Takigawa N, Kiura K. Harada D, et al. Cancers (Basel). 2014 Mar 26;6(2):708-22. doi: 10.3390/cancers6020708. Cancers (Basel). 2014. PMID: 24675568 Free PMC article.
Everolimus prolonged survival in transgenic mice with EGFR-driven lung tumors.
Yasugi M, Takigawa N, Ochi N, Ohashi K, Harada D, Ninomiya T, Murakami T, Honda Y, Ichihara E, Tanimoto M, Kiura K. Yasugi M, et al. Among authors: harada d. Exp Cell Res. 2014 Aug 15;326(2):201-9. doi: 10.1016/j.yexcr.2014.04.012. Epub 2014 Apr 25. Exp Cell Res. 2014. PMID: 24768699 Free article.
Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001.
Ichihara E, Hotta K, Nogami N, Kuyama S, Kishino D, Fujii M, Kozuki T, Tabata M, Harada D, Chikamori K, Aoe K, Ueoka H, Hosokawa S, Bessho A, Hisamoto-Sato A, Kubo T, Oze I, Takigawa N, Tanimoto M, Kiura K. Ichihara E, et al. Among authors: harada d. J Thorac Oncol. 2015 Mar;10(3):486-91. doi: 10.1097/JTO.0000000000000434. J Thorac Oncol. 2015. PMID: 25695221 Free article. Clinical Trial.
Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model.
Minami D, Takigawa N, Kato Y, Kudo K, Isozaki H, Hashida S, Harada D, Ochi N, Fujii M, Kubo T, Ohashi K, Sato A, Tanaka T, Hotta K, Tabata M, Toyooka S, Tanimoto M, Kiura K. Minami D, et al. Among authors: harada d. Cancer Sci. 2015 Oct;106(10):1296-302. doi: 10.1111/cas.12752. Epub 2015 Sep 19. Cancer Sci. 2015. PMID: 26211743 Free PMC article.
Protocol Design for the Bench to Bed Trial in Alectinib-Refractory Non-Small-Cell Lung Cancer Patients Harboring the EML4-ALK Fusion Gene (ALRIGHT/OLCSG1405).
Isozaki H, Hotta K, Ichihara E, Takigawa N, Ohashi K, Kubo T, Ninomiya T, Ninomiya K, Oda N, Yoshioka H, Ichikawa H, Inoue M, Takata I, Shibayama T, Kuyama S, Sugimoto K, Harada D, Harita S, Sendo T, Tanimoto M, Kiura K. Isozaki H, et al. Among authors: harada d. Clin Lung Cancer. 2016 Nov;17(6):602-605. doi: 10.1016/j.cllc.2016.05.005. Epub 2016 Jun 2. Clin Lung Cancer. 2016. PMID: 27405684 Clinical Trial.
192 results